Hydrogel-supported optical-microcavity sensors

Hydrogel-supported optical-microcavity sensors
复制标题

DOI:
10.1002/adma.200500261
复制
发表时间:
2005-09-16
期刊:
影响因子:
29.4
通讯作者:
Pentland, AA
Pentland, AA
中科院分区:
材料科学1区
文献类型:
--
作者:
DeLouise, LA;Fauchet, PM;Pentland, AA

文献摘要

被引文献

相似文献

随着基于硅芯片的生物医学诊断(生物传感器)和治疗(药物输送)技术的广度不断扩大,越来越需要改进生物±设备接口,用于体内和离体应用。生物±设备接口设置了各种机械、材料和准备方面的操作限制,包括样品的收集、处理和应用于设备,以及建立设备生物相容性、对生物污垢的耐受性和固定化生物反应器试剂的稳定性的要求。通常,基于硅芯片的器件(5±10 μm厚),包括微流控微机电系统(MEMS)器件,是由刚性大块硅片支撑(~ 0.5±0.6 mm厚)制造并保持连接的。这种结构可能会限制设备的功能,特别是对于微流体多孔结构,其最佳功能可能取决于流过设备的流动方向。改进生物±器件接口可以显著提高基于芯片的器件的性能特征和多功能性,同时实现新的应用。例如,可以通过开发ª智能绷带来推进伤口护理管理,该绷带的概念是将光学装置(2±10 μm厚)嵌入柔性治疗支撑基质(例如,聚合物凝胶)中。这种结构将通过使ª智能绷带ºto改善生物±设备接口
As the breadth of silicon-chip-based biomedical diagnostic (biosensors) and therapeutic (drug-delivery) technologies continues to expand, there exists a growing need to improve the biological±device interface for both in-vivo and ex-vivo applications. The biological±device interface sets operational constraints on the various mechanical, material, and preparatory aspects of how samples are collected, processed, and applied to a device, as well as on establishing requirements for device biocompatibility, tolerance towards biofouling, and the stability of immobilized bioreagents. Typically, siliconchip-based devices (5±10 μm thick), including microfluidic microelectromechanical systems (MEMS) devices, are fabricated from and remain attached to the rigid bulk-silicon wafer support (∼ 0.5±0.6 mm thick). This architecture may limit device function particularly for microfluidic porous structures, for which optimum function may depend on the directionality of flow through the device. Improving the biological±device interface could significantly advance the performance characteristics and versatility of chip-based devices while enabling new applications. For example, wound-care management could be advanced through the development of a ªsmart bandageº, which is conceptualized as an optical device (2±10 μm thick) embedded in a flexible, therapeutic support matrix (eg, polymeric gel). This architecture would improve the biological±device interface by enabling the ªsmart bandageº to